Compare CBZ & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CBZ | TMDX |
|---|---|---|
| Founded | 1987 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.5B |
| IPO Year | 1996 | 2019 |
| Metric | CBZ | TMDX |
|---|---|---|
| Price | $42.14 | $74.39 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $41.33 | ★ $148.22 |
| AVG Volume (30 Days) | 827.4K | ★ 1.1M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 134.62 | ★ 382.18 |
| EPS | ★ 1.83 | 0.20 |
| Revenue | ★ $922,003,000.00 | $605,494,000.00 |
| Revenue This Year | $3.92 | $24.25 |
| Revenue Next Year | $4.12 | $18.75 |
| P/E Ratio | ★ $23.10 | $369.10 |
| Revenue Growth | 7.79 | ★ 37.13 |
| 52 Week Low | $24.29 | $60.11 |
| 52 Week High | $77.91 | $156.00 |
| Indicator | CBZ | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 71.70 | 51.97 |
| Support Level | $27.84 | $64.87 |
| Resistance Level | $54.00 | $80.72 |
| Average True Range (ATR) | 1.91 | 3.05 |
| MACD | 0.71 | 0.63 |
| Stochastic Oscillator | 82.83 | 69.69 |
CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the maximum of its revenues from the Financial Services segment and geographically from the United States.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.